Literature DB >> 35688897

Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance.

Z Paskins1,2, O Babatunde3, A Sturrock4, L S Toh5, R Horne6, I Maidment7.   

Abstract

Systematic reviews that examine effectiveness of interventions to improve medicines optimisation do not explain how or why they work. This realist review identified that interventions which effectively optimise medicines use in osteoporosis include opportunities to address patients' perceptions of illness and treatment and/or support primary care clinician decision making.
INTRODUCTION: In people with osteoporosis, adherence to medicines is poorer than other diseases and patients report follow-up is lacking, and multiple unmet information needs. We conducted a rapid realist review to understand what contextual conditions and mechanisms enable interventions to support osteoporosis medication optimisation.
METHODS: A primary search identified observational or interventional studies which aimed to improve medicines adherence or optimisation; a supplementary second search identified research of any design to gain additional insights on emerging findings. Extracted data was interrogated for patterns of context-mechanism-outcome configurations, further discussed in team meetings, informed by background literature and the Practicalities and Perception Approach as an underpinning conceptual framework.
RESULTS: We identified 5 contextual timepoints for the person with osteoporosis (identifying a problem; starting medicine; continuing medicine) and the practitioner and healthcare system (making a diagnosis and giving a treatment recommendation; reviewing medicine). Interventions which support patient-informed decision making appear to influence long-term commitment to treatment. Supporting patients' practical ability to adhere (e.g. by lowering treatment burden and issuing reminders) only appears to be helpful, when combined with other approaches to address patient beliefs and concerns. However, few studies explicitly addressed patients' perceptions of illness and treatment. Supporting primary care clinician decision making and integration of primary and secondary care services also appears to be important, in improving rates of treatment initiation and adherence.
CONCLUSIONS: We identified a need for further research to identify a sustainable, integrated, patient-centred, and cost- and clinically effective model of long-term care for people with osteoporosis.
© 2022. The Author(s).

Entities:  

Keywords:  Medicines optimisation; Osteoporosis treatment; Realist review

Mesh:

Year:  2022        PMID: 35688897      PMCID: PMC9568441          DOI: 10.1007/s00198-022-06453-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   5.071


  55 in total

Review 1.  Low health literacy and health outcomes: an updated systematic review.

Authors:  Nancy D Berkman; Stacey L Sheridan; Katrina E Donahue; David J Halpern; Karen Crotty
Journal:  Ann Intern Med       Date:  2011-07-19       Impact factor: 25.391

2.  How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study.

Authors:  Stefano Gonnelli; Carla Caffarelli; Stefania Rossi; Ombretta Di Munno; Nazzarena Malavolta; Giancarlo Isaia; Maurizio Muratore; Giovanni D'Avola; Salvatore Gatto; Giovanni Minisola; Ranuccio Nuti
Journal:  Aging Clin Exp Res       Date:  2016-02-12       Impact factor: 3.636

3.  Compliance, persistence, and preference outcomes of postmenopausal osteoporotic women receiving a flexible or fixed regimen of daily risedronate: A multicenter, prospective, parallel group study.

Authors:  Aydan Oral; Roman Lorenc
Journal:  Acta Orthop Traumatol Turc       Date:  2015       Impact factor: 1.511

Review 4.  Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review.

Authors:  T Gleeson; M D Iversen; J Avorn; A M Brookhart; J N Katz; E Losina; F May; A R Patrick; W H Shrank; D H Solomon
Journal:  Osteoporos Int       Date:  2009-06-05       Impact factor: 4.507

5.  The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)--quality of life during the first 4 months after fracture.

Authors:  F Borgström; I Lekander; M Ivergård; O Ström; A Svedbom; V Alekna; M L Bianchi; P Clark; M D Curiel; H P Dimai; M Jürisson; R Kallikorm; O Lesnyak; E McCloskey; E Nassonov; K M Sanders; S Silverman; M Tamulaitiene; T Thomas; A N A Tosteson; B Jönsson; J A Kanis
Journal:  Osteoporos Int       Date:  2013-01-10       Impact factor: 4.507

6.  Experience gained from the implementation of the fracture liaison service in Greece.

Authors:  Polyzois Makras; George C Babis; Efstathios Chronopoulos; Theofilos Karachalios; Konstantinos Kazakos; Dionysios Paridis; Michael Potoupnis; Anastasios-Nektarios Tzavellas; Christos Valkanis; Christos Kosmidis
Journal:  Arch Osteoporos       Date:  2020-01-03       Impact factor: 2.617

7.  Improvements in osteoporosis testing and care are found following the wide scale implementation of the Ontario Fracture Clinic Screening Program: An interrupted time series analysis.

Authors:  Dorcas E Beaton; Muhammad Mamdani; Hong Zheng; Susan Jaglal; Suzanne M Cadarette; Earl R Bogoch; Joanna E M Sale; Rebeka Sujic; Ravi Jain
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 8.  Understanding the implementation of interventions to improve the management of chronic kidney disease in primary care: a rapid realist review.

Authors:  Jung Yin Tsang; Tom Blakeman; Janet Hegarty; John Humphreys; Gill Harvey
Journal:  Implement Sci       Date:  2016-04-04       Impact factor: 7.327

9.  Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis.

Authors:  Zoe Paskins; Fay Crawford-Manning; Elizabeth Cottrell; Nadia Corp; Jenny Wright; Clare Jinks; Simon Bishop; Alison Doyle; Terence Ong; Neil Gittoes; Jo Leonardi-Bee; Tessa Langley; Robert Horne; Opinder Sahota
Journal:  BMJ Open       Date:  2020-11-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.